GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (NSE:PANACEABIO) » Definitions » Market Cap

Panacea Biotec (NSE:PANACEABIO) Market Cap : ₹8,563 Mil (As of May. 06, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Panacea Biotec Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Panacea Biotec's share price for the quarter that ended in Dec. 2023 was ₹167.9. Panacea Biotec's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 61 Mil. Therefore, Panacea Biotec's market cap for the quarter that ended in Dec. 2023 was ₹10,284 Mil.

Panacea Biotec's quarterly market cap increased from Jun. 2023 (₹7,825 Mil) to Sep. 2023 (₹10,201 Mil) and increased from Sep. 2023 (₹10,201 Mil) to Dec. 2023 (₹10,284 Mil).

Panacea Biotec's annual market cap declined from Mar. 2021 (₹10,958 Mil) to Mar. 2022 (₹9,077 Mil) and declined from Mar. 2022 (₹9,077 Mil) to Mar. 2023 (₹6,643 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Panacea Biotec's Enterprise Value for Today is ₹6,930 Mil.


Panacea Biotec Market Cap Historical Data

The historical data trend for Panacea Biotec's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Market Cap Chart

Panacea Biotec Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,309.06 5,686.77 10,957.77 9,077.37 6,642.65

Panacea Biotec Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,700.68 6,642.65 7,824.79 10,201.32 10,284.01

Competitive Comparison of Panacea Biotec's Market Cap

For the Biotechnology subindustry, Panacea Biotec's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Biotec's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's Market Cap distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's Market Cap falls into.



Panacea Biotec Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Panacea Biotec's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=₹108.45*61.2508
=₹6,643

Panacea Biotec's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=₹167.9*61.2508
=₹10,284

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacea Biotec  (NSE:PANACEABIO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Panacea Biotec Market Cap Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec (NSE:PANACEABIO) Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (NSE:PANACEABIO) Headlines

No Headlines